+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pain Management Devices Market Size, Share & Trends Analysis Report by Product (RFA, Neurostimulation), by Application (Neuropathic Pain, Cancer), by Region (APAC, North America), and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 4778242
The global pain management devices market size is expected to reach USD 14.1 billion by 2030, registering a CAGR of 9.3% over the forecast period. Increasing prevalence of chronic pain and technological advancements are driving the market growth. The rising prevalence of chronic diseases, coupled with the increasing geriatric population, across the globe is another major factor augmenting the market growth. A high preference for pain management devices over oral drugs and surgical interventions is also likely to be a key growth-driving factor for the market over the forecast period. The global market is expected to witness strong growth as a result of various technological advancements in this field.



The recent electrostimulation devices that are launching in the marketplace have advancements in the form of Microelectromechanical Systems (MEMS), Artificial Intelligence (AI), and machine learning applications. In September 2020, Boston Scientific launched WaveWriter Alpha Spinal Cord Stimulator Systems for personalized pain relief, in Europe. This would significantly expand the company’s portfolio. In February 2022, Boston Scientific Corp. closed the acquisition of Baylis Medical Company, Inc. This acquisition expanded Boston Scientific’s structural heart and electrophysiology product portfolios and included the radiofrequency NRG and VersaCross Transseptal Platforms and dilators used to support left heart access.

Moreover, cases of musculoskeletal disorders, such as arthritis, osteoarthritis, orthopedic degenerative disorders, and rheumatoid arthritis, are increasing at a significant rate. This has augmented the prevalence of chronic pain in these individuals and the inability to carry out routine tasks. For instance, according to the CDC, over 24.5% of adults in the U.S. were suffering from arthritis in 2020, making this the primary reason for work disability. Most of the elective surgeries were postponed or canceled during the COVID-19 pandemic to a rise in the exposure of the patients as well as the healthcare providers, which is expected to increase the demand for pain management devices. In August 2020, the U.S. FDA issued an Emergency Use Authorization (EUA) for the non-invasive vagus nerve stimulator to assist COVID-19 patients at home with asthma-related dyspnea.

Pain Management Devices Market Report Highlights

  • In terms of revenue, the neurostimulation segment dominated the market in 2021 owing to the increasing prevalence of the neurological disorder.
  • The radiofrequency ablation segment is expected to register the fastest CAGR over the forecast period owing to the high prevalence of chronic & CVDs and the preference for minimally-invasive surgeries.
  • The neuropathic pain application segment dominated the market in 2021 due to the new product launches by industry players and the increasing prevalence of neuropathic pain.
  • The cancer application segment is expected to register the fastest CAGR over the forecast period owing to the increasing product usage for cancer-related pain.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Pain Management Devices Market

What is the estimated value of the Global Pain Management Devices Market?

The Global Pain Management Devices Market was estimated to be valued at $6.9 Billion in 2022.

What is the growth rate of the Global Pain Management Devices Market?

The growth rate of the Global Pain Management Devices Market is 9.3%, with an estimated value of $14.1 Billion by 2030.

What is the forecasted size of the Global Pain Management Devices Market?

The Global Pain Management Devices Market is estimated to be worth $14.1 Billion by 2030.

Who are the key companies in the Global Pain Management Devices Market?

Key companies in the Global Pain Management Devices Market include B Braun Melsungen AG, Baxter, Boston Scientific Corporation or Its Affiliates., Nevro Corp., Enovis, Omron Healthcare, Inc., Medtronic, Icu Medical, Inc. and Stryker.

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in the Asia Pacific
1.3.5.4 Data for primary interviews in the Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Pain Management Devices Market Outlook, 2017-2030 (USD Million)
2.2 Segment Outlook
2.3 Competitive Outlook
2.4 Pain Management Devices Market Summary, 2021
Chapter 3 Pain Management Devices Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.2 Ancillary market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Technology Timeline Overview
3.4 Pricing Analysis
3.5 Regulatory Framework
3.5.1 List of regulatory bodies
3.6 Pain Management Devices Market Dynamics
3.6.1 Market driver analysis
3.6.2 Market restraint analysis
3.7 Pain Management Devices Market Analysis Tools: Porters
3.7.1 Supplier Power
3.7.2 Buyer Power
3.7.3 Threat Of Substitutes
3.7.4 Threat Of New Entrants
3.7.5 Competitive Rivalry
3.8 PESTEL Analysis
3.8.1 Political Landscape
3.8.2 Economic Landscape
3.8.3 Social Landscape
3.8.4 Technology Landscape
3.8.5 Environmental Landscape
3.8.6 Legal Landscape
3.9 Major Deals & Strategic Alliances Analysis
3.9.1 Mergers & Acquisitions
3.9.2 product launch
3.9.3 Expansion
3.9.4 Partnership & Collaborations
3.9.5 Market Entry Strategies
3.10 Disease Prevalence Analysis
3.11 Hospitalization Cost Analysis
3.12 COVID 19 Impact Analysis
3.12.1 Current & future impact analysis
3.12.2 Opportunity analysis
3.12.3 Impact on Market Players
Chapter 4 Pain Management Devices Market: Competitive Analysis
4.1 Market Participation Categorization
4.2 Public Companies
4.2.1 Company market position analysis
4.2.2 Competitive Dashboard Analysis
4.2.2.1 Market Differentiators
4.2.3 Company Market Share
4.2.4 Competitive Dashboard Analysis
4.3 Private Companies
4.3.1 List of key emerging companies
Chapter 5 Pain Management Devices Market: Product Estimates & Trend Analysis
5.1 Product Market Share Analysis, 2021 & 2030
5.2 Product Dashboard
5.2.1 Electrical Stimulators
5.2.1.1 Electrical stimulators market estimates and forecasts, 2017-2030 (USD Million)
5.2.1.2 TENS (Transcutaneous Electrical Nerve Stimulators)
5.2.1.2.1 TENS (Transcutaneous Electrical Nerve Stimulators) market estimates and forecasts, 2017-2030 (USD Million)
5.2.1.3 Other electrical stimulators
5.2.1.3.1 Other electrical stimulators market estimates and forecasts, 2017-2030 (USD Million)
5.2.2 Radiofrequency Ablation
5.2.2.1 Radiofrequency ablation market estimates and forecasts, 2017-2030 (USD Million)
5.2.3 Analgesic Infusion Pumps
5.2.3.1 Analgesic infusion pumps market estimates and forecasts, 2017-2030 (USD Million)
5.2.3.2 Intrathecal Infusion Pumps
5.2.3.2.1 Intrathecal infusion pumps market estimates and forecasts, 2017-2030 (USD Million)
5.2.3.3 External infusion pumps
5.2.3.3.1 External infusion pumps market estimates and forecasts, 2017-2030 (USD Million)
5.2.4 Neurostimulation
5.2.4.1 Neurostimulation market estimates and forecasts, 2017-2030 (USD Million)
5.2.4.2 Spinal cord stimulators
5.2.4.2.1 Spinal cord stimulators market estimates and forecasts, 2017-2030 (USD Million)
5.2.4.3 Deep brain stimulators
5.2.4.3.1 Deep brain stimulators market estimates and forecasts, 2017-2030 (USD Million)
5.2.4.4 Sacral neurostimulators
5.2.4.4.1 Sacral neurostimulators market estimates and forecasts, 2017-2030 (USD Million)
5.2.4.5 Others
5.2.4.5.1 Others market estimates and forecasts, 2017-2030 (USD Million)
Chapter 6 Pain Management Devices Market: Application Estimates & Trend Analysis
6.1 Application Market Share Analysis, 2021 & 2030
6.2 Application Dashboard
6.3 Cancer
6.3.1 Cancer market estimates and forecasts, 2017-2030 (USD Million)
6.4 Neuropathic Pain
6.4.1 Neuropathic pain market estimates and forecasts, 2017-2030 (USD Million)
6.5 Facial & Migraine
6.5.1 Facial & migraine market estimates and forecasts, 2017-2030 (USD Million)
6.6 Musculoskeletal Disorder
6.6.1 Musculoskeletal disorder market estimates and forecasts, 2017-2030 (USD Million)
6.7 Trauma
6.7.1 Trauma market estimates and forecasts, 2017-2030 (USD Million)
6.8 Others
6.8.1 Others market estimates and forecasts, 2017-2030 (USD Million)
Chapter 7 Pain Management Devices Market: Regional Estimates & Trend Analysis, by, Product, Application
7.1 Regional Market Snapshot
7.2 Market Share Analysis by Country, 2021
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 MEA
7.3 North America
7.3.1 North America Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.3.2 U.S.
7.3.2.1 U.S. Pain Management Devices market estimates and forecasts, 2017-2030(USD Million)
7.3.3 Canada
7.3.3.1 Canada Pain Management Devices market estimates and forecasts, 2017-2030(USD Million)
7.4 Europe
7.4.1 Europe Pain Management Devices MARKET estimates and forecasts, 2017-2030 (USD Million)
7.4.2 U.K.
7.4.2.1 U.K. Pain Management Devices market estimates and forecasts, 2017-2030(USD Million)
7.4.3 Germany
7.4.3.1 Germany Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.4.4 France
7.4.4.1 France Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.4.5 Italy
7.4.5.1 Italy Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.4.6 Spain
7.4.6.1 Spain Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.4.7 Netherlands
7.4.7.1 Netherlands Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.5.2 Japan
7.5.2.1 Japan Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.5.3 China
7.5.3.1 China Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.5.4 India
7.5.4.1 India Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.5.5 Australia
7.5.5.1 Australia Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.6 Latin America
7.6.1 Latin America Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.6.2 Mexico
7.6.2.1 Mexico Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.6.3 Brazil
7.6.3.1 Brazil Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.6.4 Argentina
7.6.4.1 Argentina Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.7 MEA
7.7.1 MEA Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.7.2 South Africa
7.7.2.1 South Africa Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Saudi Arabia Pain Management Devices market estimates and forecasts, 2017-2030 (USD Million)
Chapter 8 Company Profiles
8.1 B Braun Melsungen AG
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Baxter
8.2.1 Company overview
8.2.2 Product benchmarking
8.2.3 Strategic initiatives
8.3 Boston Scientific Corporation or its affiliates.
8.3.1 Company overview
8.3.2 Financial Performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Nevro Corp.
8.4.1 Company overview
8.4.2 Financial Performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 Enovis
8.5.1 Company overview
8.5.2 Product benchmarking
8.5.3 Strategic initiatives
8.6 OMRON Healthcare, Inc.
8.6.1 Company overview
8.6.2 Financial Performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 Medtronic
8.7.1 Company overview
8.7.2 Financial Performance
8.7.3 Product benchmarking
8.7.4 Product benchmarking
8.8 ICU Medical, Inc.
8.8.1 Company overview
8.8.2 Financial Performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 Abbott
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives
8.10 Stryker
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives
8.11 Stimwave LLC
8.11.1 Company overview
8.11.2 Financial performance
8.11.3 Product benchmarking
8.11.4 Strategic initiatives

Companies Mentioned

  • B Braun Melsungen AG
  • Baxter
  • Boston Scientific Corporation or Its Affiliates.
  • Nevro Corp.
  • Enovis
  • Omron Healthcare, Inc.
  • Medtronic
  • Icu Medical, Inc.
  • Abbott
  • Stryker
  • Stimwave LLC

Methodology

Loading
LOADING...